Exciting news! ProPharma Group and The Planet Group announce merger.  Learn More >

Back to Posts

Back to Posts

August 7, 2015 FDA News

FDA Generic Drug User Fee Rates: Fiscal Year 2016

As required by the Generic Drug User Fee Amendments of 2012, FDA has announced the 2016 rates for the following user fees:

  • Abbreviated new drug application (ANDA),
  • Prior approval to an ANDA (PAS),
  • Type II active pharmaceutical ingredient drug master file (DMF),
  • Generic drug active pharmaceutical ingredient (API) facilities, and
  • Finished dosage form (FDF) facilities.

These fees are collected to ensure FDA has the needed funds to employ the staff needed to review drugs in a timely manner, thus getting drugs approved and to market in a more efficient time frame. The rates are amended annually and are effective each fiscal year, from October 1 to September 30.

The generic drug user fee rates for fiscal year 2016 are as follows:


Fee Category

Fee Rates for FY 2016

Abbreviated New Drug Application (ANDA)

$76, 030

Prior Approval Supplement (PAS) to ANDA


Drug Master File (DMF)




Fee Category

Fee Rates for FY 2016

Active Pharmaceutical Ingredient (API) – Domestic


API – Foreign


Finished Dosage Form (FDF) – Domestic


FDF – Foreign



Need help deciding which application is right for your generic product? We can help you get through FDA successfully in a more time and cost efficient manner. To learn more about how we can help, please contact us

Your Business has Complex Challenges. ProPharma Group has Exceptional Solutions.

We partner with pharmaceutical, biotechnology, and medical device clients to tackle complex challenges. Contact us to learn how our experienced team can help ensure regulatory and development success throughout the product lifecycle.

Interested in gaining an industry edge? Let us help you stay up to date.

All fields are required.